The Oncosearch | Oncotarget

Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-Î²-mediated MDSC infiltration Research Paper

Sinae Kim, Jin Hoi Song, Seokho Kim, Peng Qu, Betty K. Martin, Waheed S. Sehareen, Diana C. Haines, Pengnian C. Lin, Shyam K. Sharan, Suhwan Chang

Published Feb 3, 2016 · Vol. 7, No. 10 · pp. 11094-11112

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome Research Paper

Linlin Luo, Peter McGarvey, Subha Madhavan, Rakesh Kumar, Yuriy Gusev, Geeta Upadhyay

Published Feb 3, 2016 · Vol. 7, No. 10 · pp. 11165-11193

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells Priority Research Paper

Sofia R. Gameiro, Anthony S. Malamas, Kwong Y. Tsang, Soldano Ferrone, James W. Hodge

Published Feb 3, 2016 · Vol. 7, No. 7 · pp. 7390-7402

Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients Clinical Research Papers

Yeong C. Kim, Linli Zhao, Hanwen Zhang, Ye Huang, Jian Cui, Fengxia Xiao, Bradley Downs, San Ming Wang

Published Feb 2, 2016 · Vol. 7, No. 8 · pp. 9600-9612

The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer Research Paper

Yanan Zhang, Jie Liu, Jing Lin, Lei Zhou, Yuhua Song, Bo Wei, Xiaoli Luo, Zhida Chen, Yingjie Chen, Jiaxiu Xiong, Xiaojie Xu, Lihua Ding, Qinong Ye

Published Feb 2, 2016 · Vol. 7, No. 9 · pp. 9859-9875

DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression Research Paper

Dong Wha Jun, Mihwa Hwang, Yun-Hee Kim, Kyung-Tae Kim, Sunshin Kim, Chang-Hun Lee

Published Feb 2, 2016 · Vol. 7, No. 14 · pp. 17699-17710

A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors Research Paper

Samit Chatterjee, Wojciech G. Lesniak, Matthew Gabrielson, Ala Lisok, Bryan Wharram, Polina Sysa-Shah, Babak Behnam Azad, Martin G. Pomper, Sridhar Nimmagadda

Published Feb 2, 2016 · Vol. 7, No. 9 · pp. 10215-10227

Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women Research Paper

Hong Ling, Shan Li, Yang Wu, Yi-Zi Zheng, Feng Qiao, Ling Yao, Zhi-Gang Cao, Fu-Gui Ye, Jiong Wu, Xin Hu, Bin Wang, Zhi-Ming Shao

Published Feb 1, 2016 · Vol. 7, No. 9 · pp. 9759-9772

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts Research Paper

Babak Behnam Azad, Samit Chatterjee, Wojciech G. Lesniak, Ala Lisok, Mrudula Pullambhatla, Zaver M. Bhujwalla, Martin G. Pomper, Sridhar Nimmagadda

Published Feb 1, 2016 · Vol. 7, No. 11 · pp. 12344-12358

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay Research Paper

Maria Schwaederle, Hatim Husain, Paul T. Fanta, David E. Piccioni, Santosh Kesari, Richard B. Schwab, Kimberly C. Banks, Richard B. Lanman, AmirAli Talasaz, Barbara A. Parker, Razelle Kurzrock

Published Feb 1, 2016 · Vol. 7, No. 9 · pp. 9707-9717

Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer Review

Tae-Hwe Heo, Joseph Wahler, Nanjoo Suh

Published Jan 31, 2016 · Vol. 7, No. 13 · pp. 15460-15473

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients Research Paper

Sarah Cattin, BenoÃ®t Fellay, Sylvain Pradervand, Andreas Trojan, Thomas Ruhstaller, Curzio RÃ¼egg, Gregor FÃ¼rstenberger

Published Jan 31, 2016 · Vol. 7, No. 10 · pp. 11137-11150

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer Research Paper

Sukhbir Kaur, Abdel G. Elkahloun, Satya P. Singh, Qing-Rong Chen, Daoud M. Meerzaman, Timothy Song, Nidhi Manu, Weiwei Wu, Poonam Mannan, Susan H. Garfield, David D. Roberts

Published Jan 31, 2016 · Vol. 7, No. 9 · pp. 10133-10152

Setdb1, a novel interactor of Î”Np63, is involved in breast tumorigenesis Research Paper

Carla Regina, Mirco Compagnone, Angelo Peschiaroli, AnnaMaria Lena, Margherita Annicchiarico-Petruzzelli, Maria Cristina Piro, Gerry Melino, Eleonora Candi

Published Jan 31, 2016 · Vol. 7, No. 20 · pp. 28836-28848

Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome Research Paper

Yao Zhang, Ye Hu, Jing-Yuan Fang, Jie Xu

Published Jan 31, 2016 · Vol. 7, No. 10 · pp. 11056-11066

Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein Research Paper

Chengyong Dong, Baofeng Zhao, Fei Long, Ying Liu, Zhenzhen Liu, Song Li, Xuejun Yang, Deguang Sun, Haibo Wang, Qinlong Liu, Rui Liang, Yan Li, Zhenming Gao, Shujuan Shao, Qing Robert Miao, Liming Wang

Published Jan 31, 2016 · Vol. 7, No. 8 · pp. 8850-8865

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells Research Paper

Maria C. Palanca-Wessels, Garrett C. Booth, Anthony J. Convertine, Brittany B. Lundy, Geoffrey Y. Berguig, Michael F. Press, Patrick S. Stayton, Oliver W. Press

Published Jan 30, 2016 · Vol. 7, No. 8 · pp. 9561-9575

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors Research Paper

Monica Benvenuto, Laura Masuelli, Enrico De Smaele, Massimo Fantini, Rosanna Mattera, Danilo Cucchi, Elena Bonanno, Enrica Di Stefano, Giovanni Vanni Frajese, Augusto Orlandi, Isabella Screpanti, Alberto Gulino, Andrea Modesti, Roberto Bei

Published Jan 28, 2016 · Vol. 7, No. 8 · pp. 9250-9270

Ki-67 is required for maintenance of cancer stem cells but not cell proliferation Research Paper

Justin Cidado, Hong Yuen Wong, D. Marc Rosen, Ashley Cimino-Mathews, Joseph P. Garay, Abigail G. Fessler, Zeshaan A. Rasheed, Jessica Hicks, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Morassa Mohseni, Julia A. Beaver, David Chu, Karen Cravero, Eric S. Christenson, Arielle Medford, Austin Mattox, Angelo M. De Marzo, Pedram Argani, Ajay Chawla, Paula J. Hurley, Josh Lauring, Ben Ho Park

Published Jan 28, 2016 · Vol. 7, No. 5 · pp. 6281-6293

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer Priority Research Paper

James DuHadaway, George C. Prendergast

Published Jan 28, 2016 · Vol. 7, No. 7 · pp. 7372-7380

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-Î²-mediated MDSC infiltration Research Paper

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome Research Paper

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells Priority Research Paper

Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients Clinical Research Papers

The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer Research Paper

DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression Research Paper

A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors Research Paper

Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women Research Paper

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts Research Paper

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay Research Paper

Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer Review

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients Research Paper

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer Research Paper

Setdb1, a novel interactor of Î”Np63, is involved in breast tumorigenesis Research Paper

Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome Research Paper

Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein Research Paper

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells Research Paper

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors Research Paper

Ki-67 is required for maintenance of cancer stem cells but not cell proliferation Research Paper

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer Priority Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-Î²-mediated MDSC infiltration Research Paper

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome Research Paper

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells Priority Research Paper

Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients Clinical Research Papers

The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer Research Paper

DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression Research Paper

A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors Research Paper

Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women Research Paper

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts Research Paper

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay Research Paper

Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer Review

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients Research Paper

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer Research Paper

Setdb1, a novel interactor of Î”Np63, is involved in breast tumorigenesis Research Paper

Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome Research Paper

Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein Research Paper

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells Research Paper

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors Research Paper

Ki-67 is required for maintenance of cancer stem cells but not cell proliferation Research Paper

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer Priority Research Paper